The Patent Finder
US

Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds

US 9,884,840 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Jul 11, 2026 · High confidence

Held by Alcon Inc.
Filed Nov 2, 2016 as application 15/341,545 · Granted Feb 6, 2018
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended Jul 11, 2026
2008 2028
Clock starts
Jul 25, 2008
Term ended
Jul 11, 2026
Granted
Feb 6, 2018
base term after the term ends fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,450,344, US 9,096,569.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 25, 2008, when application 12/180,259, the earliest non-provisional in its chain, was filed (this one was filed Nov 2, 2016)Jul 25, 2028High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,450,344, US 9,096,569)capped to Jul 11, 2026High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderJul 11, 2026High confidence

This family

US 8,450,344Term ended
Jul 2026
Jul 2026
Application PCT/US2009/051569PCT application
no patent term
no patent term
US 8,759,388In force
no later than Jul 2028
no later than Jul 2028
US 9,096,569Term ended
Jul 2026
Jul 2026
US 9,512,101Term ended
Jul 2026
Jul 2026
US 9,884,840this patent
Jul 2026
Jul 2026
US 10,112,920Term ended
Jul 2026
Jul 2026
US 10,532,993Term ended
Jul 2026
Jul 2026
8 of 11 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 27, 2017
Reel 41754, frame 433
Aerie Pharmaceuticals, Inc.Aerie Distribution, Inc.Assignment of Assignor's Interest
May 8, 2017
Reel 42282, frame 834
Delong, Mitchell A.; Sturdivant, Jill Marie; Royalty, Susan M.Aerie Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jun 20, 2017
Reel 42759, frame 607
Aerie Distribution, Inc.Aerie Pharmaceuticals, Inc.Nunc Pro Tunc Assignment
Jul 23, 2018
Reel 46431, frame 500
Deerfield Partners, L.p.; Deerfield Private Design Fund III, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Management Company, L.p.Aerie Distribution, Inc.Release of Security Interest
Jul 23, 2018
Reel 46432, frame 307
Aerie Pharmaceuticals, Inc.Deerfield Private Design Fund III, L.P.Security Interest
Sep 5, 2019
Reel 50276, frame 807
Deerfield Private Design Fund III, L.P.Aerie Pharmaceuticals, Inc.Release of Security Interest
Jun 24, 2024
Reel 67822, frame 168
Aerie Pharmaceuticals, Inc.Alcon Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited